Concepedia

M. Gould

MG

Statistics

Publications

7

Citations

282

H-Index

7

Active since

1995

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Novartis (Switzerland)

Novartis (United States)

The Ohio State University

SUNY Upstate Medical University

M. Gould is an author at Roswell Park Comprehensive Cancer Center specializing in viral immunity, hiv, and immunology.

Top concepts

Publications per year

1995–2015

7

Publications

7

Prolonged administration of low-dose interleukin-2 in human immunodeficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicity

ZP Bernstein, MM Porter, M. Gould et al. · Blood · 1995 · 93 citations · Full text

Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies.

Vijay P. Khatri, Todd A. Fehniger, Robert A. Baiocchi et al. · Journal of Clinical Investigation · 1998 · 60 citations · Full text

, , +21

Pneumonia Versus Aspiration Pneumonitis in Nursing Home Residents: Prospective Application of a Clinical Algorithm

Joseph M. Mylotte, Susan Goodnough, M. Gould · Journal of the American Geriatrics Society · 2005 · 48 citations

Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic <scp>HCV</scp> genotype 1 infection (<scp>ESSENTIAL II</scp>)

Stefan Zeuzem, Robert Flisiak, John M. Vierling et al. · Alimentary Pharmacology & Therapeutics · 2015 · 41 citations · Full text

Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin

Graham R. Foster, Stefan Zeuzem, Stephen Pianko et al. · Journal of Viral Hepatitis · 2013 · 18 citations · Full text

1–5 of 7